These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 3396484

  • 21. [Efficacy and tolerability of cefixime in lower respiratory tract infections in adults. French multicentric study].
    Modai J.
    Presse Med; 1989 Oct 11; 18(32):1605-7. PubMed ID: 2530543
    [Abstract] [Full Text] [Related]

  • 22. Comparative clinical evaluation of ceftriaxone in treating lower respiratory tract infections.
    Abbate GF, Alagia I, Giaquinto E, Leonessa V, Caputi M, Guarino C, Micillo E, Catena E, Altucci P.
    Chemioterapia; 1986 Feb 11; 5(1):26-32. PubMed ID: 3955779
    [Abstract] [Full Text] [Related]

  • 23. Cefodizime once daily in the treatment of lower respiratory tract infections.
    Piovano CF, Palombini BC, Dagrosa EE, Mendoza F, Facco EB.
    Arzneimittelforschung; 1997 May 11; 47(5):674-7. PubMed ID: 9205786
    [Abstract] [Full Text] [Related]

  • 24. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L, Minns P, Hageage G.
    J Chemother; 1995 Apr 11; 7(2):153-6. PubMed ID: 7666123
    [Abstract] [Full Text] [Related]

  • 25. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L, Minns P, Hageage G.
    Adv Ther; 1995 Apr 11; 12(1):62-71. PubMed ID: 10150322
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Clinical experience with the use of a new cephalosporin (cefotaxime) in infectious bronchopulmonary pathology].
    Baldini EV, Bonucchi ME, Lodi SA, Rossi G.
    G Ital Chemioter; 1980 Apr 11; 27(2):57-68. PubMed ID: 6281114
    [No Abstract] [Full Text] [Related]

  • 28. Cefixime in the treatment of respiratory and urinary tract infections.
    Ludwig E.
    Chemotherapy; 1998 Sep 11; 44 Suppl 1():31-4. PubMed ID: 9797422
    [Abstract] [Full Text] [Related]

  • 29. The use of cefotaxime in pneumology.
    Grassi C, Colombo ML, Peona V.
    Acta Med Port; 1983 Feb 11; 4(2):87-90. PubMed ID: 6303060
    [No Abstract] [Full Text] [Related]

  • 30. [Ceftizoxime in the treatment of urinary tract and respiratory infections in liver disease patients].
    Esposito S, Galante D, Barba D.
    G Ital Chemioter; 1985 Feb 11; 32(2):361-5. PubMed ID: 3869114
    [No Abstract] [Full Text] [Related]

  • 31. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB, Canton P, Roche G, Weber M, Gérard A.
    Nouv Presse Med; 1981 Feb 26; 10(8):601-6. PubMed ID: 6259602
    [Abstract] [Full Text] [Related]

  • 32. Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study.
    Abbate GF, Alagia I, Giaquinto E, Leonessa V, Savioli L, Altucci P, Caputi M, Guarino C, Micillo E, Catena E.
    Respiration; 1986 Feb 26; 49(3):222-30. PubMed ID: 3515468
    [Abstract] [Full Text] [Related]

  • 33. [Clinical evaluation of cefmenoxime in internal medicine, with special reference to infections associated with hematological disorders].
    Uchida T, Matsuda S, Kimura H, Satoh T, Ishibashi T, Kokubun K, Umezu H, Horikawa A, Saitoh T, Sakauchi Y.
    Jpn J Antibiot; 1984 Dec 26; 37(12):2506-18. PubMed ID: 6098743
    [Abstract] [Full Text] [Related]

  • 34. [Penetration of cefotaxime into bronchial secretions].
    Bergogne-Berezin E, Morel C, Pierre J, Monrocq N, Dournovo P, Benard Y.
    Pathol Biol (Paris); 1982 Jun 26; 30(6 Pt 2):501-5. PubMed ID: 6289226
    [Abstract] [Full Text] [Related]

  • 35. [Evaluation of the effectiveness of ceftizoxime in the treatment of respiratory tract infections].
    Gialdroni Grassi G, Manara G, Mangiarotti P, Navone A.
    G Ital Chemioter; 1982 Jun 26; 29(1):49-54. PubMed ID: 6309599
    [No Abstract] [Full Text] [Related]

  • 36. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
    Beumer HM.
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan 26; 27(1):30-3. PubMed ID: 2663735
    [Abstract] [Full Text] [Related]

  • 37. [Clinical studies on ceftriaxone in the pediatric field].
    Aoyama R, Ito E, Ohnishi A, Izumi Y, Nagata K, Yokoyama M, Kuronuma T, Fujita M.
    Jpn J Antibiot; 1984 Nov 26; 37(11):2012-4. PubMed ID: 6098696
    [Abstract] [Full Text] [Related]

  • 38. [Clinical studies on cefmenoxime in the pediatric field].
    Okamoto K, Shino K, Fuke H, Watanabe K, Ozaki H.
    Jpn J Antibiot; 1982 Nov 26; 35(11):2545-54. PubMed ID: 6302336
    [Abstract] [Full Text] [Related]

  • 39. Cefotaxim induced a near fatal anaphylactic shock in an infant.
    Moreno-Ancillo A, Gil-Adrados AC.
    Allergol Immunopathol (Madr); 2012 Nov 26; 40(2):125-6. PubMed ID: 21621317
    [No Abstract] [Full Text] [Related]

  • 40. Cefodizime given in single or divided doses for the treatment of lower respiratory tract infection.
    Palombini BC, André-Alves MR, Dagrosa EE.
    Arzneimittelforschung; 1997 Mar 26; 47(3):299-302. PubMed ID: 9105549
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.